HomeCompareCGIUF vs JNJ

CGIUF vs JNJ: Dividend Comparison 2026

CGIUF yields 10.35% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CGIUF wins by $547285.25M in total portfolio value
10 years
CGIUF
CGIUF
● Live price
10.35%
Share price
$1.66
Annual div
$0.17
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$547285.28M
Annual income
$537,308,894,106.24
Full CGIUF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CGIUF vs JNJ

📍 CGIUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGIUFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGIUF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CGIUF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGIUF
Annual income on $10K today (after 15% tax)
$879.44/yr
After 10yr DRIP, annual income (after tax)
$456,712,559,990.30/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, CGIUF beats the other by $456,712,555,952.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGIUF + JNJ for your $10,000?

CGIUF: 50%JNJ: 50%
100% JNJ50/50100% CGIUF
Portfolio after 10yr
$273642.65M
Annual income
$268,654,449,428.06/yr
Blended yield
98.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CGIUF
No analyst data
Altman Z
0.5
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGIUF buys
0
JNJ buys
0
No recent congressional trades found for CGIUF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGIUFJNJ
Forward yield10.35%2.14%
Annual dividend / share$0.17$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$547285.28M$30.5K
Annual income after 10y$537,308,894,106.24$4,749.88
Total dividends collected$546610.84M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CGIUF vs JNJ ($10,000, DRIP)

YearCGIUF PortfolioCGIUF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,769$2,069.28$10,594$274.49+$2.2KCGIUF
2$18,602$4,938.91$11,294$360.69+$7.3KCGIUF
3$33,353$13,448.43$12,133$476.91+$21.2KCGIUF
4$80,757$45,069.96$13,156$635.42+$67.6KCGIUF
5$290,389$203,978.81$14,432$854.61+$276.0KCGIUF
6$1,681,693$1,370,976.46$16,056$1,162.76+$1.67MCGIUF
7$16,639,709$14,840,297.74$18,175$1,604.53+$16.62MCGIUF
8$292,270,079$274,465,590.89$21,009$2,252.68+$292.25MCGIUF
9$9,323,724,113$9,010,995,128.11$24,911$3,229.73+$9323.70MCGIUF
10$547,285,278,907$537,308,894,106.24$30,458$4,749.88+$547285.25MCGIUF

CGIUF vs JNJ: Complete Analysis 2026

CGIUFStock

ESR-REIT has been listed on the Singapore Exchange Securities Trading Limited since 25 July 2006. ESR-REIT invests in quality income-producing industrial properties and as at 31 December 2020 holds interest in a diversified portfolio of 57 properties located across Singapore, with a total gross floor area of approximately 15.1 million square feet and an aggregate property value of S$3.1 billion6. The properties are in the following business sectors: Business Park, High-Specs Industrial, Logistics/Warehouse and General Industrial, and are located close to major transportation hubs and key industrial zones island-wide.

Full CGIUF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CGIUF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGIUF vs SCHDCGIUF vs JEPICGIUF vs OCGIUF vs KOCGIUF vs MAINCGIUF vs ABBVCGIUF vs MRKCGIUF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.